CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

SAN DIEGO, May 13, 2024 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated its purchase of Elevated Softgels, LLC (“Elevated Softgels”), a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry.  Elevated Softgels has operational flexibility allowing low to large minimum order quantity (“MOQ”) production runs, allowing for efficient use of capital and the ability to increase speed to market for new product development.  Elevated Softgels is GMP-certified and FDA-registered. The acquisition creates opportunity to further increase our sales to current and new clients.  In addition, we intend to in-source production of certain of our key products.  The acquisition was structured as an equity purchase, where the Company will operate Elevated Softgels as its wholly-owned subsidiary. 

Read more at prnewswire.com

Related news for (CVSI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.